Search Results - nina+chu

1 Results

Sort By:

miR-21 as a Therapy to Intercept Pancreatic Ductal Adenocarcinoma

Unmet NeedPancreatic ductal adenocarcinomas (PDAs) are the most prevalent neoplastic disease of the pancreas. PDAs account for more than 90% of all pancreatic malignancies and are the fourth most frequent cause of cancer-related deaths worldwide. Almost all PDAs develop following the activation of the KRAS gene. This activation triggers epithelial transformation...

Published: 3/14/2025 | Inventor(s): Elizabeth Jaffee, Nina Chu, Jacquelyn Zimmerman

Keywords(s):

Category(s): Clinical and Disease Specializations > Oncology > Pancreatic Ductal Adenocarcinoma, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics > Biomarkers